Hop­ing to shake Al­ler­gan/Shire's dry eye dom­i­nance, Oys­ter Point posts pos­i­tive Phase IIb da­ta for ri­val drug

When pa­tients go to the eye doc com­plain­ing of dry, itchy eyes, they’re usu­al­ly giv­en some lu­bri­cat­ing eye drops and per­haps a low-dose steroid to help with in­flam­ma­tion. Some­times that’s enough to man­age the dis­com­fort. Some­times it’s not, and docs will move on to pre­scrib­ing drugs like Al­ler­gan’s Resta­sis or Shire’s Xi­idra. But these drugs don’t pro­vide fast re­lief. Some­times they can take weeks, even months in Resta­sis’ case, to pro­vide a ther­a­peu­tic ef­fect.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER